An elegant lesson: larger sheaths make simpler retrievals. 16Fr catheter fragment ➡️ 24 Fr sheath. Emory University Interventional Radiology Mircea Cristescu Mohammed Faisal Loya, M.D. J. David Prologo, MD, FSIR, ABOM-D @billmajdalany Janice Newsome MD FSIR SIR RFS

Excited to delve into this with Dr. Pickhardt; technology with real potential to benefit cancer patients. New review in AJR CT-Derived Body Composition Assessment as a Prognostic Tool in Oncologic Patients: From Opportunistic Research to A… pubmed.ncbi.nlm.nih.gov/35642760/

Proud to have presented our work in oncology an longevity at #SIRBOS22. Thank you to mentors and colleagues. So much more to be done! #jobsnotfinished

Grateful to collaborate and learn from this awesome group! Percutaneous cholangioscopy can be incredibly useful for patients. 🔍⚕️

🎇Thrilled to announce I will be joining as an attending Interventional Radiologist at Memorial Sloan Kettering Cancer Center. Deepest gratitude to all my mentors and colleagues➡️too many to list! Excited pay it forward and work with exceptional oncology providers.

Use of Metformin and Survival in Patients with Hepatocellular Carcinoma (HCC) Undergoing Liver Directed Therapy: Analysis of a Nationwide Cancer Registry Kumar Mukherjee, Mo Elsayed, MD, Nima Kokabi & coauthors link.springer.com/article/10.100…

#clinicalinvestigation Use of #Metformin and Survival in Patients with Hepatocellular Carcinoma (#HCC) Undergoing Liver Directed Therapy: Analysis of a Nationwide #Cancer Registry link.springer.com/article/10.100… Mo Elsayed, MD

By 2043, interventional oncology will resemble surgical oncology, with a comprehensive clinical infrastructure including outpatient clinics, clinical and research fellows, advanced practice providers, and inpatient units. bit.ly/3pCoeX9

⚡️Honored to publish this feature in Radiology, highlighting the incredible growth of Interventional Oncology. Many brilliant minds making important contributions—the future is bright! Link: bit.ly/3pCoeX9

Fresh off the press! Super proud of this work 🤩 ✅ Metformin use can improve tumor response after locoregional therapy in HCC Check it out! 👉 mdpi.com/2072-6694/15/1…

Amazing work by a rising star! Eshani Choksi, DO Nima Kokabi MD SIR RFS

First results of the CM8HW are out! Nivo/ipi vs chemo in 1st line dMMR mCRC. We knew it would be positive, but wow 🤯 HR 0.21 for PFS and + across all subgroups. No crossing of the curves! Toxicity very manageable (don’t be scared of low dose ipi1).

With a truly commendable methodology the Dutch COLLISION trial shows non-inferiority of thermal ablation to resection for small (<3cm) colorectal cancer liver metastases #ASCO24 #crcsm meetings.asco.org/2024-asco-annu…

Online First: Results from the COLLISION trial: Thermal #ablation versus #surgical resection of small-size #ColorectalLiverMetastases: an international, randomised, controlled, phase 3 non-inferiority trial thelancet.com/journals/lanon…

Important recent Annals of Surgical Oncology study from WashU Medicine Department of Surgery looking retrospectively at long-term outcomes of near-complete responses who undergo #WatchAndWait for rectal cancer. Almost all patients received SCRT followed by consolidation chemo-->48% cCR, 28% near-complete (NCR), and

0/ Lung cryoablation (LCA) is a powerful yet underutilized tool in thoracic oncology. Our international team reviews patient selection, technique, complications, and imaging outcomes to master LCA in practice 🧵👇 RadioGraphics RadioGraphics_Editor Cooky Menias Lea Alhilali, MD #RGphx

1/ Minimally invasive thoracic interventions are more than salvage therapy. They're tools for curation, palliation, & consolidation. Let's walk through the key approaches 🧵 RadioGraphics Cooky Menias Lea Alhilali, MD Sophie McKenney Memorial Sloan Kettering Cancer Center Costi Sofocleous, MD, PhD, FSIR, FCIRSE

First United States⁩ ⁦Siemens Healthineers⁩ Biograph ONE PET/MRI. Ready for installation in the Center for Clinical Imaging Research ⁦WashU Medicine Mallinckrodt Institute of Radiology⁩ (signed for in 2018 - well worth the wait!) ⁦

There's been amazing progress against liver cancer over the last 60 years (Specifically, hepatocellular carcinoma treated with surgery) What's driven the progress? Earlier detection, safer and better operations, better biomarkers, and better treatment of recurrence

Fascinating approach for an all too common problem. Amazing developments happening in NeuroIR!